HIT Consultant

JANUARY 9, 2025

The Power of Proprietary Systems: Compliance and Uniformity Veteran data scientists who have spent decades working with SAS will be quick to argue its strengths. While proprietary systems like SAS require hefty licensing fees, open-source tools are, of course, free. And lets not forget costthe real elephant in the room.

Compliance 52

Compliance Pharmaceutical Industry Licensing Governance 52

Verisys

FEBRUARY 7, 2024

The more you know about the people in your organization, the safer you are from risks that could damage your company, your reputation, or your compliance.The regulations in the pharmaceutical industry are understandably strict, and to ensure your organization is compliant, every member of your team must be thoroughly vetted.

Licensing 52

Licensing Compliance Compliance Framework Fraud 52

SQA

JUNE 3, 2024

The Administrative Measures are comprised of the following seven chapters, encompassing a total of 79 articles that mainly address the administration of drug supply licenses, obligations of businesses supplying drugs and medical institutions using drugs, as well as regulators supervision of stakeholders in drug supply and use.

FDA 40

FDA COVID-19 Licensing Nurses 40

Verisys

JULY 13, 2023

How to Tackle Pharma’s 3 Biggest Compliance Risks Head-On with Verisys How often have you started at a new organization and heard these phrases? “ Some companies make decisions based on compliance standards and optics, while others may be more lax. Clinical trial compliance can offer unique challenges for pharmaceutical companies.

Compliance 52

Compliance Due Diligence Pharmaceutical Industry Fraud 52

Hall Render

FEBRUARY 18, 2022

License wait times reach crisis levels for healthcare workers. Only 14% of Hospitals Met Price Transparency Rule Compliance. Outpatient push being felt in architecture industry. Bill on prescription drug pricing inspires support from Maine residents, opposition from pharmaceutical industry.

COVID-19 40

COVID-19 Nursing Homes Nurses COVID-19 Vaccine 40

SQA

FEBRUARY 26, 2024

The reported irregularities and the manufacturing conditions of the products, that is, compliance with Good Manufacturing Practices, were verified on the spot. After receiving complaints, ANVSA performed joint inspections with local health surveillance agencies.

FDA 52

FDA Compliance COVID-19 Public Health 52

SQA

FEBRUARY 26, 2024

After receiving complaints, ANVSA performed joint inspections with local health surveillance agencies.The reported irregularities and the manufacturing conditions of the products, that is, compliance with Good Manufacturing Practices,were verifiedon the spot.

FDA 40

FDA Compliance COVID-19 Public Health 40